Tel.: +34 91 736 2385
LOCAL TIME
Contact: Cristina Miralles
Hours: Mon-Fri 8:30-15:00
01:12
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

BSH 2020 VIRTUAL

 

9-14 November 2020 Virtual Conference
FAQs
   
Discussion forum - BSH 2020 VIRTUAL
    Topic - ALL and AML

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
  
 Thread / Poster  Author  Replies  Last reply
BCAT1 increases sensitivity to Cytarabine and confers CXXC motif derived resistance to pro-oxidant treatment in Acute Myeloid Leukaemia cells  James Hillier 1      11/9/2020 12:01:00 PM  
Whose choice is it anyway? A multi-national and multi-stakeholder perspective on shared treatment decision making in older adults with acute myeloid leukaemia  Luke Glover 1      11/9/2020 12:01:00 PM  
Combination therapies targeting DNA Damage signalling as a therapeutic strategy in Acute Myeloid Leukaemia.  Laura Monaghan 1      11/9/2020 12:01:00 PM  
The clinical significance of FLT3-ITD allele burden in AML; a long-term retrospective single centre study.  AJ Duguid 1      11/9/2020 12:01:00 PM  
Genetic and genomic characterisation of older adults with acute lymphoblastic leukemia treated on the UKALL14 and UKALL60 clinical trials  Annie Collins 1      11/9/2020 12:01:00 PM  
Antibody Immunotherapy treatment for adults with B - Acute Lymphoblastic Leukaemia A Real-World Analysis.  Tania Dexter 1      11/9/2020 12:01:00 PM  
Relapsed Acute Lymphoblastic Leukaemia Diagnosed Using Femoral Head Histology  Jennifer Ryan 1      11/9/2020 12:01:00 PM  
Use of next generation sequencing to identify AML with germline predisposition; an essential diagnostic test  AJ Duguid 1      11/9/2020 12:01:00 PM  
Whole genome profiling of adult B-other acute lymphoblastic leukaemia on the UKALL14 trial  Daniel Leongamornlert 1      11/9/2020 12:01:00 PM  
The role of nutrition in aggressive haematological malignancies a single-centre review of patients receiving intensive chemotherapy  Graham Mcilroy 1      11/9/2020 12:01:00 PM  
Synergistic inhibition of FLT3-ITD Acute Myeloid Leukaemia cell growth in vitro using combination of FLT3 inhibitor quizartinib and standard chemotherapeutic agent cytarabine (also known as AraC)  Salihanur Darici 1      11/9/2020 12:01:00 PM  
Single Hospital Retrospective Review of patients in Treatment Free Remission (TFR) following therapy with Tyrosine Kinase Inhibitors (TKIs) for Chronic Myeloid Leukemia (CML)  Sumant Kundu 1      11/9/2020 12:01:00 PM  
Single Centre Experience in Use of Leukapheresis for Management of Leukostasis in High Count Leukaemia.  Fenella Willis 1      11/9/2020 12:01:00 PM  
Inotuzumab ozogamicin vs. blinatumomab for adults with Philadelphia chromosome-negative relapsed/refractory B-cell acute lymphoblastic leukaemia in Scotland: corresponding cost-effectiveness and relative treatment effect.  Alex Legg 1      11/9/2020 12:01:00 PM  
Combination Therapies Targeting Apoptosis pathways in Paediatric AML  Ahlam Ali 1      11/9/2020 12:01:00 PM  
High Risk Cytogenetic Abnormalities in Acute Myeloid Leukemia-Single Centre Experience  Shawana Kamran 1      11/9/2020 12:01:00 PM  
Analysis of Treatment Patterns and Outcomes for Patients With Therapy-related Acute Myeloid Leukaemia and Acute Myeloid Leukaemia With Myelodysplasia-related Changes Diagnosed in England Between 20112016 Using Hospital Episode Statistics  Alex Legg 1      11/9/2020 12:01:00 PM  
Incidence and management of PEGylated-asparaginase related thrombosis in adults with ALL  Matthew Poynton 1      11/9/2020 12:01:00 PM  
Evaluating Vyxeos use in routine clinical practice; data from the South East Scotland Cancer Network  Valarmathi Anandhan 1      11/9/2020 12:01:00 PM  
Identification of a new target patient population for ibrutinib treatment.  Barbara Guinn 1      11/9/2020 12:01:00 PM  
19 courses of CPX-351 for the treatment of AML  Stephen Boyd 1      11/9/2020 12:01:00 PM  
Regulation of Acute Myeloid Leukaemia Maintenance by Wilms Tumour 1 in an Isoform Specific Manner  Sandeep Potluri 1      11/9/2020 12:01:00 PM  
Could CD45 have a role in the development of myeloid malignancies?  Maryam Al Barashdi 1      11/9/2020 12:01:00 PM  
Inhibition of Myeloid Cell Leukaemia 1 (MCL1) overcomes Bromodomain and Extra-Terminal (BET) inhibition resistance in Acute Myeloid Leukaemia (AML) cells  Eleni Ladikou 1      11/9/2020 12:01:00 PM  
Exploration of the variant composition in the genome of pediatric and adult recurrent acute myeloid leukemia  Svea Stratmann 1      11/9/2020 12:01:00 PM  
Platelet recovery after the first cycle of DA chemotherapy for AML is an independent predictor of survival  Sandra Sookramanien 1      11/9/2020 12:01:00 PM  
The utility of flow cytometry in the diagnosis of acute monocytic and monoblastic leukaemias  Huw Richards 1      11/9/2020 12:01:00 PM  
Efficacy of FMS-like Tyrosine Kinase 3 (FLT3) Inhibitors in Patients with Acute Myeloid Leukemia  Thomas Erblich 1      11/9/2020 12:01:00 PM  
The impact of PCR thermocycling conditions, DNA template concentration and inter-operator variation on determining allelic ratio in the detection of FLT3-ITD mutations in AML.  Andy Robinson 1      11/9/2020 12:01:00 PM  
Outcomes following treatment discontinuation in chronic myeloid leukaemia ( CML ): real-world experience from 3 regional UK centres  Farooq Wandroo 1      11/9/2020 12:01:00 PM  
BCAT1 increases sensitivity to Cytarabine and confers CXXC motif derived resistance to pro-oxidant treatment in Acute Myeloid Leukaemia cells  James Hillier 1      11/5/2020 7:52:00 PM  
The impact of PCR thermocycling conditions, DNA template concentration and inter-operator variation on determining allelic ratio in the detection of FLT3-ITD mutations in AML.  Andy Robinson 1      11/2/2020 10:05:00 PM  
       




Most viewed poster for this congress
Poster: 1
Visits: 407
Title: Whole genome profiling of adult B-other acute lymphoblastic leukaemia on the UKALL14 trial
Authors: Daniel Leongamornlert , E. Barretta, S. Lee, T. Creasey, R. Mitchell, A. A. Kirkwood, L Clifton-Hadley, P. Patrick, P. Campbell, B. Patel, A. Moorman, A. K. Fielding, E. Papaemmanuil
Centre: 

Poster most viewed in this topic
Poster: 1
Visits: 407
Title: Whole genome profiling of adult B-other acute lymphoblastic leukaemia on the UKALL14 trial
Authors: Daniel Leongamornlert , E. Barretta, S. Lee, T. Creasey, R. Mitchell, A. A. Kirkwood, L Clifton-Hadley, P. Patrick, P. Campbell, B. Patel, A. Moorman, A. K. Fielding, E. Papaemmanuil
Centre: 


 




PosterSessionOnline
Logo Draft
 
Logo Cert